Viral vector manufacturing for gene therapy

Wednesday, March 20, 2024 at 12:20 PM to 12:40 PM · 20 min. (Europe/London)
Viral Vector Manufacturing [Track 9]
Presentation
AGC Biologics
69
AGC Biologics is a global CDMO providing pharmaceutical development and manufacturing services for protein-based biologics and cell and gene therapies. With seven facilities and teams of scientists across three continents, we have the resources and the available capacity you need to accelerate your race to GMP. From development, to clinical trials, to full-scale commercialization, we can help you reach your goals at any stage in the drug development and manufacturing process. We specialize in the following modalities and substances, mammalian and microbial-based therapeutic proteins, recombinant DNA, plasmid DNA (pDNA), viral vectors, Messenger RNA (mRNA) and genetically engineered cells. Our services range from Process Development, Analytical Development, cGMP Manufacturing, Quality Control and Quality Assurance and Process Validation. We forge exceptionally strong partnerships with our clients and we never lose sight of our commitment to deliver reliable and compliant drug substance.

Registered attendees

Auffret-Cariou Adrien
Auffret-Cariou Adrien
Process Development ProjectsSK pharmteco
Carlotta Peticone
Carlotta Peticone
Associate DirectorOrchard Therapeutics Ltd
Francesca Di Pasquale
Francesca Di Pasquale
Director R&DQIAGEN GmbH

Log in

See all the content and easy-to-use features by logging in or registering!